Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Omnicell Inc OMCL

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.


NDAQ:OMCL - Post by User

Bullboard Posts
Post by mart33on Mar 27, 2008 7:40pm
260 Views
Post# 14914085

completed its $40.0million program to repurchase s

completed its $40.0million program to repurchase sOmnicell,Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, announced today that it has completed its $40.0million program to repurchase shares of its Common Stock. A total of 2,133,898 shares were repurchased at an average price of $18.75.mARCH 12.2008
The stock is in uptrend with resistance at 21$. If $21 is breached it may test 22-23 area.
Bullboard Posts